RECRUITINGOBSERVATIONAL
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Utilization of the Natural History of Medullary Thyroid Carcinoma to Inform Advanced Disease Management
About This Trial
This study utilizes a multi-institutional registry to describe the natural history of medullary thyroid cancer that has spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) in understanding disease management. The goal of this study is to learn about how medullary thyroid cancer develops and progresses.
Who May Be Eligible (Plain English)
Who May Qualify:
- Aims 1 and 2: A diagnosis of MTC
- Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment
- Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team
- Aim 3: A current registrant in the MTCR
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Aims 1 and 2: A diagnosis of MTC
* Aims 1 and 2: A registrant in the Medullary Thyroid Cancer Registry (MTCR). Patients of all disease phases will be eligible for enrollment
* Aim 3: A diagnosis of advanced phase (red or gray) MTC as determined by clinical team
* Aim 3: A current registrant in the MTCR
Treatments Being Tested
OTHER
Blood Pressure Measurement
Undergo blood pressure measurement
OTHER
Questionnaire Administration
Complete questionnaires
Locations (2)
University of California San Francisco
San Francisco, California, United States
M D Anderson Cancer Center
Houston, Texas, United States